Long-Term Observation of Prognostic Factors and Clinical Outcome of Vernal Keratoconjunctivitis in Childhood

Overview

Journal Clin Ophthalmol

Publisher Dove Medical Press

Specialty Ophthalmology

Date 2024 Aug 28

PMID 39193318

Authors

Asami Shimokawa

Aya Ikeda

Kazuhiro Harada

Rie Takahashi

Jane Huang

Tomoko Tsukahara-Kawamura

Hiroaki Ozaki

Eiichi Uchio

Affiliations

Soon will be listed here.

Abstract

Purpose: Vernal keratoconjunctivitis (VKC) is a refractory ocular allergic disorder that mainly affects boys. Long-term follow-up has been rarely reported for VKC. We investigated the long-term clinical outcome of VKC to identify relevant clinical features of prognostic value based on follow-up for a median of 70 months.

Methods: In total, 45 consecutive patients clinically diagnosed with VKC aged 4 to 12 years at onset at the Department of Ophthalmology of Fukuoka University Hospital were included. Patients were treated with immunosuppressive eye drops without simultaneous corticosteroid eye drops, except for the occurrence of exacerbations. Collated variables were gender, age at onset, clinical score of ocular lesions (conjunctival giant papillae, limbal edema and corneal epithelial lesions) at the first visit, and clinical score of atopic dermatitis (AD) at baseline. Cumulative cure rate was estimated using Kaplan-Meier method. A binomial logistic predictive model was used to determine the most reliable clinical predictors of VKC outcome.

Results: The observation period ranged from 24 to 188 months, with median of 70 months. Among the 45 cases enrolled, all non-cured cases (14 cases) observed clinically were complicated by AD. Cumulative cure rate was 74.5% and 84.9% at eight- and ten-year follow-up, respectively. Ten-year cumulative cure rates of cases with and without AD were 50.5% and 100%, respectively, and a significant difference was found between these cumulative cure curves. Binomial regression analysis revealed that AD and gender were significantly related to worse outcome, and this binomial regression model had high sensitivity and specificity.

Conclusion: This study demonstrated that th eclinical outcomeof VKC might be predicted by several factors that can beobtained in the early clinical phase. Information on the long-term prognosis of VKC patients might play an important role for precision medicine for VKC in childhood.

References

Foster C . The pathophysiology of ocular allergy: current thinking. Allergy. 1995; 50(21 Suppl):6-9; discussion 34-8. DOI: 10.1111/j.1398-9995.1995.tb04250.x. View

Daniell M, Constantinou M, Vu H, Taylor H . Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol. 2006; 90(4):461-4. PMC: 1857014. DOI: 10.1136/bjo.2005.082461. View

Fujita H, Ueno T, Suzuki S, Harada K, Tsukahara-Kawamura T, Ozaki H . Classification of Subtypes of Vernal Keratoconjunctivitis by Cluster Analysis Based on Clinical Features. Clin Ophthalmol. 2023; 17:3271-3279. PMC: 10625392. DOI: 10.2147/OPTH.S431798. View

Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y . A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010; 26(2):165-74. PMC: 3158389. DOI: 10.1089/jop.2009.0087. View

Neumann E, Gutmann M, BLUMENKRANTZ N, MICHAELSON I . A review of four hundred cases of vernal conjunctivitis. Am J Ophthalmol. 1959; 47(2):166-72. DOI: 10.1016/s0002-9394(14)76417-7. View

Bremond-Gignac D, Donadieu J, Leonardi A, Pouliquen P, Doan S, Chiambarretta F . Prevalence of vernal keratoconjunctivitis: a rare disease?. Br J Ophthalmol. 2008; 92(8):1097-102. DOI: 10.1136/bjo.2007.117812. View

Bremond-Gignac D, Nischal K, Mortemousque B, Gajdosova E, Granet D, Chiambaretta F . Atopic Keratoconjunctivitis in Children: Clinical Features and Diagnosis. Ophthalmology. 2015; 123(2):435-437. DOI: 10.1016/j.ophtha.2015.07.012. View

Ikezawa Z, Miyakawa K, Komatsu H, Suga C, Miyakawa J, Sugiyama A . A probable involvement of rice allergy in severe type of atopic dermatitis in Japan. Acta Derm Venereol Suppl (Stockh). 1992; 176:103-7. DOI: 102340/00015555176103107. View

Kosrirukvongs P, Vichyanond P, Wongsawad W . Vernal keratoconjunctivitis in Thailand. Asian Pac J Allergy Immunol. 2003; 21(1):25-30. View

10.

Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J . A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2009; 25(4):365-72. DOI: 10.1089/jop.2008.0103. View

11.

Leonardi A, Brun P, Abatangelo G, Plebani M, Secchi A . Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003; 44(7):3052-8. DOI: 10.1167/iovs.02-0766. View

12.

Jongvanitpak R, Vichyanond P, Jirapongsananuruk O, Visitsunthorn N, Pacharn P . Clinical characteristics and outcomes of ocular allergy in Thai children. Asian Pac J Allergy Immunol. 2020; 40(4):407-413. DOI: 10.12932/AP-160519-0564. View

13.

Uchio E, Kimura R, Migita H, Kozawa M, Kadonosono K . Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy. Graefes Arch Clin Exp Ophthalmol. 2007; 246(2):291-6. DOI: 10.1007/s00417-007-0697-z. View

14.

Miyazaki D, Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y . Japanese guidelines for allergic conjunctival diseases 2020. Allergol Int. 2020; 69(3):346-355. DOI: 10.1016/j.alit.2020.03.005. View

15.

Uchio E, Miyakawa K, Ikezawa Z, Ohno S . Systemic and local immunological features of atopic dermatitis patients with ocular complications. Br J Ophthalmol. 1998; 82(1):82-7. PMC: 1722359. DOI: 10.1136/bjo.82.1.82. View

16.

Vichyanond P, Pacharn P, Pleyer U, Leonardi A . Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatr Allergy Immunol. 2014; 25(4):314-22. DOI: 10.1111/pai.12197. View

17.

Hirota A, Shoji J, Inada N, Shiraki Y, Yamagami S . Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus. Cornea. 2021; 41(1):23-30. PMC: 8647698. DOI: 10.1097/ICO.0000000000002692. View

18.

Kausar A, Akhtar N, Akbar N . Epidemiological Aspects Of Allergic Conjunctivitis. J Ayub Med Coll Abbottabad. 2022; 34(1):135-140. DOI: 10.55519/JAMC-01-9432. View

19.

Leonardi A . Management of vernal keratoconjunctivitis. Ophthalmol Ther. 2014; 2(2):73-88. PMC: 4108143. DOI: 10.1007/s40123-013-0019-y. View

20.

Buckley R . Vernal keratoconjunctivitis. Int Ophthalmol Clin. 1988; 28(4):303-8. DOI: 10.1097/00004397-198802840-00009. View